Claims
- 1. A method of producing a plant with an improved agronomic or nutritional characteristic by engineering the plant for ectopic overexpression of one or several nitrogen assimilation/metabolism enzymes, wherein a plant with an improved agronomic or nutritional characteristic exhibits:
i) faster rate of growth, ii) greater fresh or dry weight at maturation, iii) greater fruit or seed yield, iv) greater total plant nitrogen content, v) greater fruit or seed nitrogen content, vi) greater free amino acid content in the whole plant, or vii) greater free amino acid content in the fruit or seed, viii) greater protein content in seed or fruit, viiii) greater protein content in a vegetative tissue, than an identically cultivated unengineered, progenitor plant, when said plant and said progenitor plant are cultivated under nitrogen non-limiting growth conditions; the overexpressed nitrogen assimilation/metabolism enzyme is an aspartate aminotransferase, glutamate 2-oxoglutarate aminotransferase, glutamate dehydrogenase, asparaginase, eukaryotic asparagine synthetase or cytosolic glutamine synthetase; and the engineering for ectopic overexpression of one or several nitrogen assimilation/metabolism enzymes comprises: i) transforming the plant with one or several gene fusions that confer ectopic overexpression of one or several of said nitrogen assimilation/metabolism enzymes, ii) selecting or identifying the transformed plant based on the trait conferred by a marker gene linked to said gene fusion, iii) screening the transformed plant for one or more of above said improved agronomic or nutritional characteristics when said transformed plant is cultivated under nitrogen non-limiting growth conditions, iv) selecting the transformed plant with one or more improved agronomic or nutritional characteristic.
- 2. The method of claim 1, wherein the gene fusion comprises a gene encoding a nitrogen assimilation/metabolism enzyme operably linked to a strong, constitutively expressed plant promoter.
- 3. The method of claim 2, wherein said strong, constitutively expressed plant promoter is a CaMV 35S promoter.
- 4. The method of claim 3, wherein the nitrogen assimilation/metabolism enzyme is an eukaryotic asparagine synthetase or cytosolic glutamine synthetase.
- 5. The method of claim 4, wherein the nitrogen assimilation/metabolism enzyme is a root-specific glutamine synthetase.
- 6. The method of claim 1, wherein the gene fusion is the 35S-GS gene fusion of pZ3, pZ9, or pZ17.
- 7. The method of claim 1, wherein the gene fusion is the 35S-AS gene fusion of pZ127.
- 8. A plant produced by the method of any of claims 1 to 7.
- 9. A seed of a plant produced by the method of any of claims 1 to 7, wherein said seed contains one or several of said gene fusions that confer ectopic overexpression of one or several of said nitrogen assimilation/metabolism enzymes.
- 10. A plant of the seed of claim 9.
- 11. A method of producing a plant with a suppressed level of glutamine synthetase by engineering the plant for ectopic overexpression of a glutamine synthetase gene, wherein the suppressed level of glutamine synthetase is in comparison with identically cultivated unengineered, progenitor plant; and the engineering of the plant comprises:
i) transforming the plant with a gene fusion designed to confer ectopic overexpression of a glutamine synthetase gene, ii) selecting or identifying the transformed plant based on the trait conferred by a marker gene linked to said gene fusion, iii) screening the transformed plant for an abnormally low level of glutamine synthetase, and iv) selecting the transformed plant with an abnormally low level of glutamine synthetase.
- 12. The method of claim 11, wherein said glutamine synthetase gene is a gene encoding chloroplastic glutamine synthetase.
- 13. The method of claim 12, wherein the gene fusion is the 35S-GS fusion of pZ41 or pZ54.
- 14. A method of producing a plant with a suppressed level of asparagine synthetase by engineering the plant for ectopic overexpression of an inactive asparagine synthetase, wherein the suppressed level of asparagine synthetase is in comparison with identically cultivated unengineered, progenitor plant; and the engineering of the plant comprises
i) transforming the plant with a gene fusion that confers ectopic overexpression of an inactive asparagine synthetase, ii) selecting or identifying the transformed plant based on the trait conferred by a marker gene linked to said gene fusion, iii) screening the transformed plant for an abnormally low level of asparagine synthetase, and iv) selecting the transformed plant with an abnormally low level of asparagine synthetase.
- 15. The method of claim 14, wherein the gene fusion is the 35S-AS fusion of pZ167.
- 16. A progeny, clone, cell line or cell of a plant produced by the method of any of claims 1 to 7, wherein said progeny, clone, cell line or cell contains one or several of said gene fusions that confer ectopic overexpression of one or several of said nitrogen assimilation/metabolism enzymes.
- 17. A genetically engineered plant which (a) ectopically overexpresses a gene encoding an aspartate aminotransferase, glutamate 2-oxoglutarate aminotransferase, glutamate dehydrogenase, asparaginase, eukaryotic asparagine synthetase or cytosolic glutamine synthetase, and (b) exhibits one or more of the following improved agronomic or nutritional characteristics:
i) faster rate of growth, ii) greater fresh or dry weight at maturation, iii) greater fruit or seed yield, iv) greater total plant nitrogen content, v) greater fruit or seed nitrogen content, vi) greater free amino acid content in the whole plant, or vii) greater free amino acid content in the fruit or seed, viii) greater protein content in seed or fruit, viiii) greater protein content in a vegetative tissue, than an identically cultivated unengineered, progenitor plant, when said plant and said progenitor plant are cultivated under nitrogen non-limiting growth conditions.
- 18. The genetically engineered plant of claim 17, wherein the cytosolic glutamine synthetase is a root-specific glutamine synthetase.
Priority Claims (1)
Number |
Date |
Country |
Kind |
11-376710 |
Dec 1999 |
JP |
|
Parent Case Info
[0001] This application is a continuation-in-part of co-pending application Ser. No. 08/132,334 filed Oct. 6, 1993, which is hereby incorporated by reference in its entirety.
Government Interests
[0002] This invention was made with government support under grant no.:GM32877 awarded by the National Institute of Health, and grant nos.:DEFG0292 and ER20071 awarded by the Department of Energy. The government has certain rights in the invention.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08132334 |
Oct 1993 |
US |
Child |
09729821 |
Dec 2000 |
US |